Will West, CellCentric CEO

Ex­clu­sive: Pfiz­er to in­vest $25M in­to tiny UK biotech with epi­ge­net­ics ap­proach to can­cer

Cam­bridge, UK-based start­up Cell­Cen­tric is re­ceiv­ing $25 mil­lion to fin­ish on­go­ing clin­i­cal stud­ies and get some ex­tra run­way in the form of a cash in­fu­sion from one of the world’s largest phar­mas.

Pfiz­er is giv­ing Cell­Cen­tric the funds as a strate­gic in­vest­ment, Cell­Cen­tric CEO Will West told End­points News, get­ting ac­cess to what he said would be the “in­side seat” as more da­ta ma­te­ri­al­ize.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.